Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00YEO
|
|||
| Former ID |
DIB010347
|
|||
| Drug Name |
NZ-1002
|
|||
| Synonyms |
Mucopolysaccharidosis I (MPS I) therapy, Novazyme; Phosphorylated alpha-L-iduronidase, Novazyme
Click to Show/Hide
|
|||
| Indication | Lysosomal storage disease [ICD-11: 5C56.Z; ICD-10: E75-E77] | Terminated | [1] | |
| Company |
Novazyme Pharmaceuticals Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Enzyme unspecific (Enz) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015179) | |||
| REF 2 | Expression of a cytokinin synthesis gene from Agrobacterium tumefaciens T-DNA in basket willow (Salix viminalis). Physiologia Plantarum Volume 88, Issue 3, pages 439-445, July 1993. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.